drugset / Trial / NCT01780974

Pilot Study: Lipoic Acid and Omega-3 Fatty Acids for Alzheimer's Prevention

NCT01780974

Phase 1/2 Completed 42 enrolled Oregon Health and Science University
RandomizedParallel-groupTriple-blindPrevention

Summary

The primary aim of the pilot study is to provide data that can be used to better determine sample size for the design of a larger clinical trial. The pilot will evaluate the effectiveness of Lipoic Acid (LA) plus Omega-3 fatty acids (Omega-3) on preventing Alzheimer's Disease (AD). The investigators will also collect data to evaluate recruitment rate, safety, and compliance over the 12 month study period.

Timeline

Start
2013-04
Primary completion
2015-10
Completion
2015-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Fish oil concentrate Unknown 3000 mg
Subject alpha-lipoic acid Small molecule 600 mg

Indications

No indication recorded.